Company profile: AVM Biotech
1.1 - Company Overview
Company description
- Provider of clinical-stage AVM0703, a proprietary concentrated dexamethasone formulation that mobilizes unique immune cells to target cancer and autoimmune diseases; offers Phase 2 enrollment for relapsed/refractory Non-Hodgkin’s lymphoma and leukemia, compassionate use/expanded access to AVM0703, and licensing for collaborations, global strategic development, partnerships, and out-licensing across multiple indications.
Products and services
- Clinical Trial Enrollment: Ongoing Phase 2 clinical study currently actively enrolls patients with relapsed/refractory Non-Hodgkin’s Lymphoma and leukemia
- AVM0703: Proprietary concentrated dexamethasone formulation designed to mobilize unique immune cells for targeting cancer and autoimmune diseases
- Compassionate Use/Expanded Access Program: Expanded-access pathway offers AVM0703 to patients with serious or life-threatening conditions who lack other therapeutic options
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to AVM Biotech
Sarissa Biomedical
HQ: United Kingdom
Website
- Description: Provider of minimally invasive microelectrode electrochemical biosensors that detect purines and other neurochemicals, such as serotonin and dopamine, in blood to aid diagnosis and monitoring of neurological disorders. Solutions offer exquisite sensitivity, broad linear range, rapid measurements, and high accuracy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sarissa Biomedical company profile →
Artesyn Biosolutions
HQ: Ireland
Website
- Description: Provider of single-use valves, components, and systems for the biopharmaceutical industry, designed and manufactured to support increased efficiency in biopharmaceutical production.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Artesyn Biosolutions company profile →
BCF Life Sciences
HQ: France
Website
- Description: Provider of natural amino acids and derivatives for the pharmaceutical and health care industries. Specialises in extracting L-Cystine and L-Tyrosine of 100% traced origin and derivatives such as Carbocisteine. Offers L-Cystine, L-Tyrosine, Carbocisteine (expectorant API), Cysti-White, Kera-Diet keratin hydrolysate, and Leafamine (17 free amino acids) for food supplements, baby foods, and sustainable agriculture.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BCF Life Sciences company profile →
Halo Labs
HQ: United States
Website
- Description: Provider of biopharmaceutical quality control tools and particle analysis systems using optics, image processing, and microfluidics. Offerings include Aura+ analyzers; Aura PTx for protein therapy stability; Aura GT for viral vector stability; Aura CL for cell therapy particle characterization; Particle Vue software (21 CFR Part 11); and 0.8 µm black membrane plates.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Halo Labs company profile →
Avitide
HQ: United States
Website
- Description: Provider of customized affinity purification solutions for biopharmaceuticals, including AVIPure affinity resins for custom and platform use, proprietary solutions to improve bioprocessing and manufacturing, a flexible, scalable commercial resin supply supported by ISO 9001:2015 operations, regulatory support and documentation, and AVIPure-AAV8 for single-step AAV8 purification with high yield, purity, and capacity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avitide company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for AVM Biotech
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to AVM Biotech
2.2 - Growth funds investing in similar companies to AVM Biotech
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for AVM Biotech
4.2 - Public trading comparable groups for AVM Biotech
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →